secwatch.observer — SEC 8-K summary
======================================

Issuer:     TransMedics Group, Inc. (TMDX)
CIK:        0001756262
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001193125-23-178575
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransMedics amends credit agreement to permit acquisitions up to $50M each, extends amortization start to 2026
--------------------------------------------------------------------------------

- Second Amendment to Credit Agreement with CIBC allows cash consideration up to $50M per acquisition, $150M total.
- Amortization start date for term loans extended to July 31, 2026 (from July 31, 2025).
- Company must maintain at least $100M unrestricted cash with CIBC or affiliates to make earn-out payments.
- Permitted acquisitions subject to conditions: no event of default, compliance with covenants, not unfriendly.
- Existing letters of credit (e.g., $250K standby L/C) included in Cash Management Services definition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756262/000119312523178575/0001193125-23-178575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756262/000119312523178575/d504683d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-178575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer